Table 1 Patient characteristics
All patients N = 2625 | COVID-19 period N = 1005 | Non-COVID-19 period N = 1620 | p-value | |
|---|---|---|---|---|
Age, mean ± SD, y | 68 ± 17 | 68 ± 17 | 69 ± 17 | 0.137 |
Sex (Male), No./total (%) | 1747/2625 (66.6) | 676/1005 (67.3) | 1071/1620 (66.1) | 0.552 |
Medical history, No./total (%) | ||||
- Diabetes | 395/2625 (15.0) | 156/1005 (15.5) | 239/1620 (14.8) | 0.613 |
- Cardiovascular | 1249/2625 (47.6) | 478/1005 (47.6) | 771/1620 (47.6) | 1.000 |
- Respiratory | 409/2625 (15.6) | 160/1005 (15.9) | 249/1620 (15.2) | 0.740 |
- Other | 746/2625 (28.4) | 262/1005 (26.1) | 484/1620 (29.9) | 0.036 |
- None | 155/2625 (5.9) | 46/1005 (4.6) | 109/1620 (6.7) | 0.026 |
OHCA location (home), No./total (%) | 1975/2483 (75.5) | 819/971 (84.4) | 1156/1512 (76.5) | < 0.001 |
OHCA cause, No./total (%) | 0.002 | |||
- Cardiac | 2001/2625 (76.2) | 726/1005 (72.2) | 1275/1620 (78.7) | |
- Respiratory | 470/2625 (17.9) | 210/1005 (20.9) | 260/1620 (16.0) | |
- Neurological | 44/2625 (1.7) | 19/1005 (1.9) | 25/1620 (1.5) | |
- Other medical cause | 110/2625 (4.2) | 50/1005 (5.0) | 60/1620 (3.7) | |
Survival ROSC, No./total (%) | 604/2615 (23.1) | 195/999 (19.5) | 409/1616 (25.3) | 0.001 |
D30 Survival, No./total (%) | 125/2483 (5.1) | 26/937 (2.8) | 99/1546 (6.4) | 0.001 |